Lawrence F. Colwell

Statistics

Publications

Citations

2.9K

H-Index

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Ionis Pharmaceuticals (United States)

Karo Pharma (Sweden)

Lawrence F. Colwell is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1991–2018

Publications

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

Jun Wang, S.M. Soisson, Katherine Young et al. · Nature · 2006 · 815 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro

Giovanni Migliaccio, Joanne E. Tomassini, Steven S. Carroll et al. · Journal of Biological Chemistry · 2003 · 325 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties

David B. Olsen, Anne B. Eldrup, Linda Bartholomew et al. · Antimicrobial Agents and Chemotherapy · 2004 · 234 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Linda Brockunier, Emma R. Parmee, Hyun Ok et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 199 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Structure−Activity Relationship of Heterobase-Modified 2‘-<i>C</i>-Methyl Ribonucleosides as Inhibitors of Hepatitis C Virus RNA Replication

Anne B. Eldrup, Marija Prhavc, Jennifer L. Brooks et al. · Journal of Medicinal Chemistry · 2004 · 186 citations

Pharmacy, Biochemistry, Pharmacology +17

1–5 of 34